The colours of amphetamine-induced cardiomyopathy

J Cardiovasc Med (Hagerstown). 2020 May;21(5):396-397. doi: 10.2459/JCM.0000000000000922.

Authors

Bostjan Berlot^{1

2

3}, Matthew G L Williams^{1

2}, Chiara Bucciarelli-Ducci^{1

2}

Affiliations

¹ Bristol Heart Institute, Bristol National Institute of Health Research (NIHR) Biomedical Research Centre, University Hospitals Bristol NHS Trust and University of Bristol.
² Bristol Medical School, University of Bristol, Bristol, UK.
³ Department of Cardiology, University Medical Centre Ljubljana, Ljubljana, Slovenia.

PMID: 31895130
DOI: 10.2459/JCM.0000000000000922

No abstract available

Publication types

Case Reports

MeSH terms

Administration, Inhalation
Adult
Amphetamine / administration & dosage
Amphetamine / adverse effects*
Amphetamine-Related Disorders / complications*
Amphetamine-Related Disorders / diagnosis
Cardiomyopathies / chemically induced
Cardiomyopathies / diagnostic imaging*
Cardiomyopathies / physiopathology
Cardiotoxicity
Central Nervous System Stimulants / administration & dosage
Central Nervous System Stimulants / adverse effects*
Color*
Heart Failure / chemically induced
Heart Failure / diagnostic imaging*
Heart Failure / physiopathology
Humans
Image Interpretation, Computer-Assisted*
Magnetic Resonance Imaging, Cine*
Male
Predictive Value of Tests

Substances

Central Nervous System Stimulants
Amphetamine